# Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients

> **NCT01489969** · PHASE2 · COMPLETED · sponsor: **Neurim Pharmaceuticals Ltd.** · enrollment: 137 (actual)

## Conditions studied

- Primary Insomnia

## Interventions

- **DRUG:** Neu-P11

## Key facts

- **NCT ID:** NCT01489969
- **Lead sponsor:** Neurim Pharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-05
- **Final completion:** 2013-01
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489969, "Sleep Laboratory Study to Investigate the Safety and Efficacy of Neu-P11 in Primary Insomnia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01489969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*